Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -5.06%4.99B | -7.75%3.21B | -9.65%1.45B | -2.01%7.04B | -0.31%5.26B | 3.41%3.48B | 4.92%1.61B | 3.51%7.18B | 4.46%5.27B | 5.07%3.37B |
| Operating income | -5.06%4.99B | -7.75%3.21B | -9.65%1.45B | -2.01%7.04B | -0.31%5.26B | 3.41%3.48B | 4.92%1.61B | 3.51%7.18B | 4.46%5.27B | 5.07%3.37B |
| Cost of sales | -38.90%-1.46B | -26.58%-818.94M | -4.86%-315.52M | -5.05%-1.48B | -1.02%-1.05B | 3.50%-646.99M | 11.56%-300.89M | -14.31%-1.41B | -20.76%-1.04B | -25.58%-670.44M |
| Operating expenses | -38.90%-1.46B | -26.58%-818.94M | -4.86%-315.52M | -5.05%-1.48B | -1.02%-1.05B | 3.50%-646.99M | 11.56%-300.89M | -14.31%-1.41B | -20.76%-1.04B | -25.58%-670.44M |
| Gross profit | -16.10%3.53B | -15.58%2.39B | -12.99%1.14B | -3.74%5.56B | -0.64%4.2B | 5.13%2.83B | 9.62%1.31B | 1.17%5.77B | 1.09%4.23B | 0.97%2.7B |
| Selling expenses | 20.98%-1.79B | 15.80%-1.17B | 15.23%-543.64M | 0.81%-2.99B | 0.53%-2.27B | -3.46%-1.39B | -22.59%-641.28M | -5.10%-3.01B | -4.05%-2.28B | -1.22%-1.35B |
| Administrative expenses | 3.62%-389.05M | 1.28%-263.69M | 12.39%-131.02M | 0.59%-534.81M | -5.89%-403.64M | -11.23%-267.11M | -0.26%-149.55M | -7.09%-537.98M | 4.60%-381.18M | 8.76%-240.14M |
| Research and development expenses | 18.65%-805.78M | 19.06%-527.16M | 18.43%-274.14M | 2.23%-1.32B | 0.21%-990.46M | -2.18%-651.3M | -3.61%-336.07M | 4.84%-1.35B | 10.11%-992.55M | 11.16%-637.38M |
| Special items of operating profit | -39.83%140.82M | -38.90%101.47M | -53.73%43.86M | 9.26%288.55M | 18.13%234.05M | 24.72%166.07M | 42.79%94.79M | -19.36%264.1M | -20.29%198.13M | -27.51%133.16M |
| Operating profit | -12.20%677.03M | -23.02%530M | -15.47%233.36M | -11.77%1B | 0.05%771.09M | 13.86%688.47M | 4.91%276.08M | -8.83%1.14B | 4.97%770.71M | 11.46%604.67M |
| Financing income | -16.39%504.01M | -16.34%342.19M | -19.50%177.07M | -4.71%791.91M | -5.09%602.84M | -4.39%409.03M | -2.24%219.97M | 47.06%831.01M | 61.62%635.19M | 78.14%427.83M |
| Special items of earning before tax | 480.78%120.73M | 73.12%-11.96M | 76.32%-11.64M | -474.47%-109.09M | -245.62%-31.71M | -34.32%-44.49M | -56.30%-49.13M | 158.54%29.13M | 160.33%21.77M | -62.80%-33.13M |
| Earning before tax | -3.01%1.3B | -18.31%860.23M | -10.77%398.79M | -15.58%1.69B | -5.99%1.34B | 5.37%1.05B | -2.15%446.92M | 13.31%2B | 30.84%1.43B | 31.10%999.38M |
| Tax | -328.43%-135.32M | 31.45%-116.93M | 17.65%-56.33M | 12.74%-62.96M | -157.00%-31.58M | -88.52%-170.57M | -25.09%-68.4M | -216.79%-72.16M | -60.05%55.41M | -114.66%-90.48M |
| After-tax profit from continuing operations | -11.00%1.17B | -15.77%743.31M | -9.53%342.46M | -15.69%1.62B | -11.63%1.31B | -2.91%882.44M | -5.86%378.52M | 5.52%1.93B | 20.59%1.48B | 26.21%908.9M |
| Earning after tax | -11.00%1.17B | -15.77%743.31M | -9.53%342.46M | -15.69%1.62B | -11.63%1.31B | -2.91%882.44M | -5.86%378.52M | 5.52%1.93B | 20.59%1.48B | 26.21%908.9M |
| Minority profit | 14.95%-42.49M | 21.28%-28.98M | 11.31%-14.17M | -483.52%-57.77M | -810.48%-49.96M | -2,655.99%-36.82M | -364.83%-15.98M | 67.59%-9.9M | 82.44%-5.49M | 95.96%-1.34M |
| Profit attributable to shareholders | -11.15%1.21B | -15.99%772.29M | -9.60%356.64M | -13.13%1.68B | -8.60%1.36B | 0.99%919.26M | -2.71%394.5M | 4.32%1.94B | 18.04%1.49B | 20.84%910.24M |
| Basic earnings per share | -9.56%2.46 | -14.67%1.57 | -7.69%0.72 | -13.02%3.34 | -7.48%2.72 | 2.79%1.84 | -2.50%0.78 | 6.08%3.84 | 20.49%2.94 | 23.45%1.79 |
| Diluted earnings per share | -9.26%2.45 | -14.75%1.56 | -8.97%0.71 | -13.05%3.33 | -8.16%2.7 | 2.23%1.83 | -1.27%0.78 | 5.80%3.83 | 20.49%2.94 | 23.45%1.79 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS | UAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | PricewaterhouseCoopers | -- | -- | -- | PricewaterhouseCoopers | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.